{"transactions":[{"id":4621666,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2026-09-17T21:03:38.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":48076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date.  Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":119024,"source":{"system":"sec-edgar","filing":"0001193125-26-394488","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526394488/ownership.xml","form_type":"4"}},{"id":964650,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":5915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 9,149 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 5,915 PSUs. The remaining 3,234 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 9,149 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 5,915 PSUs. The remaining 3,234 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5915},"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964649,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-15","kind":"grant","planned":true,"acquired":true,"shares":56440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option was granted for a total of 56,440 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":56440,"derivative":{"exercise_price":66.62,"expiration_date":"2035-12-15","underlying":"Class A Common Stock","underlying_shares":56440},"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964648,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-15","kind":"grant","planned":true,"acquired":true,"shares":12816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":12816,"derivative":{"underlying":"Class A Common Stock","underlying_shares":12816},"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964647,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":2491,"price":67.2637,"value":167553.8767,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The shares were sold in multiple transactions at prices ranging from $66.52 to $67.51, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.  The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":70563,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964646,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":2371,"price":67.1705,"value":159261.2555,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares were sold in multiple transactions at prices ranging from $67.00 to $67.38, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":73054,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964645,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":6738,"price":66.5758,"value":448587.7404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares were sold in multiple transactions at prices ranging from $65.98 to $66.97, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":75425,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964644,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":2530,"price":66.62,"value":168548.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 53,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":82163,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964643,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":9252,"price":67.54,"value":624880.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 58,657 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":84693,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964642,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":5915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 71,103 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":93945,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":964641,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-17T21:39:52.000Z","date":"2025-12-15","kind":"grant","planned":true,"acquired":true,"shares":25633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 25,633 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 71,103 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":88030,"source":{"system":"sec-edgar","filing":"0001193125-25-323425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525323425/ownership.xml","form_type":"4"}},{"id":981268,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-03T18:55:31.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 19,500 shares."}],"balance_after":0,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001193125-25-307131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525307131/ownership.xml","form_type":"4"}},{"id":981267,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-03T18:55:31.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":67.5635,"value":304035.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $67.115 to $67.95, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":62397,"source":{"system":"sec-edgar","filing":"0001193125-25-307131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525307131/ownership.xml","form_type":"4"}},{"id":981266,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-12-03T18:55:31.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":true,"shares":4500,"price":64.6,"value":290700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":66897,"source":{"system":"sec-edgar","filing":"0001193125-25-307131","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000119312525307131/ownership.xml","form_type":"4"}},{"id":1119346,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-06T19:58:55.000Z","date":"2025-06-04","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 19,500 shares."}],"balance_after":4500,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-083386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025083386/ownership.xml","form_type":"4"}},{"id":1119345,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-06-06T19:58:55.000Z","date":"2025-06-04","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":75.0191,"value":1125286.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $75.00 to $75.125, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":62397,"source":{"system":"sec-edgar","filing":"0000950170-25-083386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025083386/ownership.xml","form_type":"4"}},{"id":1119344,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-06-06T19:58:55.000Z","date":"2025-06-04","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":64.6,"value":969000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":77397,"source":{"system":"sec-edgar","filing":"0000950170-25-083386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025083386/ownership.xml","form_type":"4"}},{"id":1124489,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-06-03T16:44:00.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":350,"price":74.97,"value":26239.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares sold in the reported transaction consist of 350 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025."}],"balance_after":62397,"source":{"system":"sec-edgar","filing":"0000950170-25-081036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025081036/ownership.xml","form_type":"4"}},{"id":1287111,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-03T20:29:47.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 56,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":16000,"derivative":{"exercise_price":62.32,"expiration_date":"2027-12-15","underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-25-012643","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025012643/ownership.xml","form_type":"4"}},{"id":1287110,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-02-03T20:29:47.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":86.0041,"value":2150102.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $86.00 to $86.195, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":62397,"source":{"system":"sec-edgar","filing":"0000950170-25-012643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025012643/ownership.xml","form_type":"4"}},{"id":1287109,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-02-03T20:29:47.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":83,"value":1245000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":87397,"source":{"system":"sec-edgar","filing":"0000950170-25-012643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025012643/ownership.xml","form_type":"4"}},{"id":1287108,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2025-02-03T20:29:47.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":62.32,"value":2492800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":102397,"source":{"system":"sec-edgar","filing":"0000950170-25-012643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017025012643/ownership.xml","form_type":"4"}},{"id":1326400,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":false,"shares":5192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,378 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,192 PSUs. The remaining 2,186 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,378 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 5,192 PSUs. The remaining 2,186 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5192},"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326399,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-16","kind":"grant","planned":true,"acquired":true,"shares":35307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 35,307 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":35307,"derivative":{"exercise_price":77.91,"expiration_date":"2034-12-16","underlying":"Class A Common Stock","underlying_shares":35307},"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326398,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-16","kind":"grant","planned":true,"acquired":true,"shares":10042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":10042,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10042},"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326397,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-17","kind":"sale","planned":true,"acquired":false,"shares":7713,"price":78.2208,"value":603317.0304,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares were sold in multiple transactions at prices ranging from $78.06 to $78.52, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":62397,"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326396,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-17","kind":"sale","planned":true,"acquired":false,"shares":4625,"price":77.8349,"value":359986.4125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares were sold in multiple transactions at prices ranging from $77.02 to $78.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":70110,"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326395,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":8867,"price":79.18,"value":702089.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 45,470 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":74735,"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326394,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":true,"shares":5192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 61,483 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":83602,"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1326393,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-12-18T21:21:34.000Z","date":"2024-12-16","kind":"grant","planned":true,"acquired":true,"shares":20085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 20,085 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 61,483 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":78410,"source":{"system":"sec-edgar","filing":"0000950170-24-138158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024138158/ownership.xml","form_type":"4"}},{"id":1497624,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-05-30T16:30:08.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":false,"shares":1998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares.  The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":1998},"source":{"system":"sec-edgar","filing":"0000950170-24-066668","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024066668/ownership.xml","form_type":"4"}},{"id":1497623,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-05-30T16:30:08.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":2283,"price":79.62,"value":181772.46,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":58325,"source":{"system":"sec-edgar","filing":"0000950170-24-066668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024066668/ownership.xml","form_type":"4"}},{"id":1497622,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2024-05-30T16:30:08.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":true,"shares":1998,"price":62.32,"value":124515.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares include 285 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":60608,"source":{"system":"sec-edgar","filing":"0000950170-24-066668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000095017024066668/ownership.xml","form_type":"4"}},{"id":1704516,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":5738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,136 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,738 PSUs. The remaining 1,398 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 7,136 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,738 PSUs. The remaining 1,398 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5738},"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704515,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":29316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option was granted for a total of 29,316 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":29316,"derivative":{"exercise_price":87.49,"expiration_date":"2033-12-15","underlying":"Class A Common Stock","underlying_shares":29316},"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704514,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":8363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":8363,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8363},"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704513,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-19","kind":"sale","planned":false,"acquired":false,"shares":1663,"price":86.0122,"value":143038.2886,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares were sold in multiple transactions at prices ranging from $85.89 to $86.138, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":58325,"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704512,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-18","kind":"sale","planned":false,"acquired":false,"shares":8856,"price":86.1868,"value":763270.3008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares were sold in multiple transactions at prices ranging from $85.86 to $86.78, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":59988,"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704511,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1637,"price":87.49,"value":143221.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 41,398 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":68844,"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704510,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":8713,"price":88.6,"value":771971.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 44,698 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":70481,"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704509,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":5738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 56,529 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":79194,"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1704508,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-12-19T19:34:59.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":16726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 16,726 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 56,529 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":73456,"source":{"system":"sec-edgar","filing":"0001209191-23-059261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123059261/doc4.xml","form_type":"4"}},{"id":1829472,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-07-14T16:34:31.000Z","date":"2023-07-12","kind":"exercise","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares."}],"balance_after":1998,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-23-042270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123042270/doc4.xml","form_type":"4"}},{"id":1829471,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-07-14T16:34:31.000Z","date":"2023-07-12","kind":"sale","planned":false,"acquired":false,"shares":21000,"price":89,"value":1869000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":56730,"source":{"system":"sec-edgar","filing":"0001209191-23-042270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123042270/doc4.xml","form_type":"4"}},{"id":1829470,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-07-14T16:34:31.000Z","date":"2023-07-12","kind":"exercise","planned":false,"acquired":true,"shares":21000,"price":62.32,"value":1308720.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares include 356 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023."}],"balance_after":77730,"source":{"system":"sec-edgar","filing":"0001209191-23-042270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123042270/doc4.xml","form_type":"4"}},{"id":1897958,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-10T16:51:37.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":false,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares."}],"balance_after":22998,"derivative":{"exercise_price":62.32,"expiration_date":"2024-12-15","underlying":"Class A Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001209191-23-028505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123028505/doc4.xml","form_type":"4"}},{"id":1897957,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-10T16:51:37.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":false,"shares":11118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was originally granted for a total of 52,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":11118},"source":{"system":"sec-edgar","filing":"0001209191-23-028505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123028505/doc4.xml","form_type":"4"}},{"id":1897956,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-05-10T16:51:37.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":2180,"price":84.3527,"value":183888.886,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $84.10 to $84.735, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":56374,"source":{"system":"sec-edgar","filing":"0001209191-23-028505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123028505/doc4.xml","form_type":"4"}},{"id":1897955,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-05-10T16:51:37.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":12820,"price":83.4653,"value":1070025.146,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $83.07 to $84.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":58554,"source":{"system":"sec-edgar","filing":"0001209191-23-028505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123028505/doc4.xml","form_type":"4"}},{"id":1897954,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-05-10T16:51:37.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":true,"shares":3882,"price":62.32,"value":241926.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":71374,"source":{"system":"sec-edgar","filing":"0001209191-23-028505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123028505/doc4.xml","form_type":"4"}},{"id":1897953,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-05-10T16:51:37.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":true,"shares":11118,"price":45.5,"value":505869.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":67492,"source":{"system":"sec-edgar","filing":"0001209191-23-028505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123028505/doc4.xml","form_type":"4"}},{"id":2028173,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-07T21:08:06.000Z","date":"2023-02-03","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was originally granted for a total of 52,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":11118,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-007699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123007699/doc4.xml","form_type":"4"}},{"id":2028172,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-02-07T21:08:06.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":2413,"price":83.6454,"value":201836.3502,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $83.22 to $83.85, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":56374,"source":{"system":"sec-edgar","filing":"0001209191-23-007699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123007699/doc4.xml","form_type":"4"}},{"id":2028171,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-02-07T21:08:06.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":12000,"price":85,"value":1020000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":58787,"source":{"system":"sec-edgar","filing":"0001209191-23-007699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123007699/doc4.xml","form_type":"4"}},{"id":2028170,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel & Secretary"}}],"security":"Class A Common Stock","published_at":"2023-02-07T21:08:06.000Z","date":"2023-02-03","kind":"exercise","acquired":true,"shares":12000,"price":45.5,"value":546000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":70787,"source":{"system":"sec-edgar","filing":"0001209191-23-007699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919123007699/doc4.xml","form_type":"4"}},{"id":2077565,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-22T16:12:46.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":1638,"price":68.09,"value":111531.42,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":58787,"source":{"system":"sec-edgar","filing":"0001209191-22-062429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062429/doc4.xml","form_type":"4"}},{"id":2081330,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-16","kind":"exercise","acquired":false,"shares":5344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,600 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 5,344 PSUs. The remaining 1,256 PSUs were cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,600 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 5,344 PSUs. The remaining 1,256 PSUs were cancelled."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5344},"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081329,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":32944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was granted for a total of 32,944 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":32944,"derivative":{"exercise_price":71.07,"expiration_date":"2032-12-15","underlying":"Class A Common Stock","underlying_shares":32944},"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081328,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":9149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":9149,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9149},"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081327,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":332,"price":70.444,"value":23387.408,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The shares were sold in multiple transactions at prices ranging from $70.27 to $70.70, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":60425,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081326,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":4738,"price":69.8021,"value":330722.3498,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The shares were sold in multiple transactions at prices ranging from $69.257 to $70.20, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":60757,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081325,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-19","kind":"tax_withholding","acquired":false,"shares":1612,"price":70.8,"value":114129.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":65495,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081324,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":2334,"price":70.6604,"value":164921.3736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares were sold in multiple transactions at prices ranging from $70.433 to $71.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held following the reported transactions include 43,053 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":67107,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081323,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-16","kind":"tax_withholding","acquired":false,"shares":3574,"price":71.07,"value":254004.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held following the reported transactions include 43,053 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":69441,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081322,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-16","kind":"exercise","acquired":true,"shares":5344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 46,353 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":73015,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081321,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":18299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Award represents a total of 18,299 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2022. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 46,353 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":67671,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2081320,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-12-19T21:40:21.000Z","date":"2022-12-15","kind":"tax_withholding","acquired":false,"shares":2510,"price":73.17,"value":183656.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 28,054 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Shares include 281 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2022."}],"balance_after":49372,"source":{"system":"sec-edgar","filing":"0001209191-22-062075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122062075/doc4.xml","form_type":"4"}},{"id":2406102,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2022-02-09T20:36:50.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":1798,"price":77.23,"value":138859.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":51601,"source":{"system":"sec-edgar","filing":"0001209191-22-008259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919122008259/doc4.xml","form_type":"4"}},{"id":2463645,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-20T20:40:56.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":1638,"price":90.69,"value":148550.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":53399,"source":{"system":"sec-edgar","filing":"0001209191-21-070706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070706/doc4.xml","form_type":"4"}},{"id":2463644,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-20T20:40:56.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":1663,"price":90.17,"value":149952.71,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":55037,"source":{"system":"sec-edgar","filing":"0001209191-21-070706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070706/doc4.xml","form_type":"4"}},{"id":2463643,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-20T20:40:56.000Z","date":"2021-12-17","kind":"tax_withholding","acquired":false,"shares":1612,"price":92,"value":148304.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":56700,"source":{"system":"sec-edgar","filing":"0001209191-21-070706","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070706/doc4.xml","form_type":"4"}},{"id":2469605,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-16T21:25:30.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":30545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option was granted for a total of 30,545 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2021, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":30545,"derivative":{"exercise_price":91.8,"expiration_date":"2031-12-15","underlying":"Class A Common Stock","underlying_shares":30545},"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2469604,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2021-12-16T21:25:30.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":7378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":7378,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7378},"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2469603,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-16T21:25:30.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":332,"price":91.9024,"value":30511.5968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The shares were sold in multiple transactions at prices ranging from $91.81 to $92.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 38,561 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":58312,"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2469602,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-16T21:25:30.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":1432,"price":90.9659,"value":130263.1688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares were sold in multiple transactions at prices ranging from $90.65 to $91.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 38,561 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":58644,"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2469601,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-16T21:25:30.000Z","date":"2020-12-16","kind":"tax_withholding","acquired":false,"shares":1637,"price":91.8,"value":150276.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 38,561 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":60076,"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2469600,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-16T21:25:30.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":14757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Award represents a total of 14,757 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2021. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 41,861 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":61713,"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2469599,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-12-16T21:25:30.000Z","date":"2021-12-15","kind":"tax_withholding","acquired":false,"shares":3506,"price":90.55,"value":317468.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 27,104 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Shares include 452 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2021."}],"balance_after":46956,"source":{"system":"sec-edgar","filing":"0001209191-21-070104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121070104/doc4.xml","form_type":"4"}},{"id":2812195,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-03T16:12:27.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":23118,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-016831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121016831/doc4.xml","form_type":"4"}},{"id":2812194,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-03-03T16:12:27.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":13000,"price":100,"value":1300000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50010,"source":{"system":"sec-edgar","filing":"0001209191-21-016831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121016831/doc4.xml","form_type":"4"}},{"id":2812193,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-03-03T16:12:27.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":13000,"price":45.5,"value":591500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":63010,"source":{"system":"sec-edgar","filing":"0001209191-21-016831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121016831/doc4.xml","form_type":"4"}},{"id":2853883,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-17T16:40:44.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":36118,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-011290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121011290/doc4.xml","form_type":"4"}},{"id":2853882,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-17T16:40:44.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":13000,"price":95,"value":1235000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50010,"source":{"system":"sec-edgar","filing":"0001209191-21-011290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121011290/doc4.xml","form_type":"4"}},{"id":2853881,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-17T16:40:44.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":13000,"price":45.5,"value":591500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":63010,"source":{"system":"sec-edgar","filing":"0001209191-21-011290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121011290/doc4.xml","form_type":"4"}},{"id":2874260,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":23118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This performance-based stock option award was granted for a total of 26,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 24,700 shares."}],"balance_after":0,"derivative":{"exercise_price":45.5,"expiration_date":"2023-12-15","underlying":"Class A Common Stock","underlying_shares":23118},"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874259,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":2882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":49118,"derivative":{"exercise_price":45.5,"expiration_date":"2026-12-15","underlying":"Class A Common Stock","underlying_shares":2882},"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874258,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":496,"price":92.23,"value":45746.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50010,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874257,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":22622,"price":91.5798,"value":2071718.2356,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $91.135 to $92.08, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50506,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874256,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":23118,"price":45.5,"value":1051869.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":73128,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874255,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":175,"price":92.23,"value":16140.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50010,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874254,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":2707,"price":91.4796,"value":247635.2772,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $91.17 to $92.08, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50185,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874253,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":2882,"price":45.5,"value":131131.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":52892,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874252,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":227,"price":92.23,"value":20936.21,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50010,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2874251,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2021-02-08T21:19:34.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":1436,"price":91.6774,"value":131648.7464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $91.22 to $91.94, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":50237,"source":{"system":"sec-edgar","filing":"0001209191-21-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919121008662/doc4.xml","form_type":"4"}},{"id":2935949,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2020-12-21T17:51:35.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":1638,"price":91.9594,"value":150629.4972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $91.66 to $92.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":51673,"source":{"system":"sec-edgar","filing":"0001209191-20-064695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919120064695/doc4.xml","form_type":"4"}},{"id":2935948,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2020-12-21T17:51:35.000Z","date":"2020-12-17","kind":"tax_withholding","acquired":false,"shares":1612,"price":91.03,"value":146740.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 34,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":53311,"source":{"system":"sec-edgar","filing":"0001209191-20-064695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919120064695/doc4.xml","form_type":"4"}},{"id":2939662,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-17T19:27:06.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":30553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 30,553 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2020, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":30553,"derivative":{"exercise_price":92.08,"expiration_date":"2030-12-15","underlying":"Class A Common Stock","underlying_shares":30553},"source":{"system":"sec-edgar","filing":"0001209191-20-064236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919120064236/doc4.xml","form_type":"4"}},{"id":2939661,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2020-12-17T19:27:06.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":7136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":7136,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7136},"source":{"system":"sec-edgar","filing":"0001209191-20-064236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919120064236/doc4.xml","form_type":"4"}},{"id":2939660,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2020-12-17T19:27:06.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":337,"price":91.6558,"value":30888.0046,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares were sold in multiple transactions at prices ranging from $91.42 to $92, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 37,422 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":54923,"source":{"system":"sec-edgar","filing":"0001209191-20-064236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919120064236/doc4.xml","form_type":"4"}},{"id":2939659,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":71288,"kind":"person","name":"SHERMAN MARK ANDREW","position":1,"cik":"0001256708","reported_name":"SHERMAN MARK ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GEN. COUN. & SECRTY"}}],"security":"Class A Common Stock","published_at":"2020-12-17T19:27:06.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":3065,"price":90.6194,"value":277748.461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares were sold in multiple transactions at prices ranging from $90.147 to $91.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 37,422 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":55260,"source":{"system":"sec-edgar","filing":"0001209191-20-064236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256708/000120919120064236/doc4.xml","form_type":"4"}}],"next_cursor":"2020-12-17T19:27:06.000000Z,2939659"}